Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Nov 17;17(22):8501.
doi: 10.3390/ijerph17228501.

Clinical Risk and Overall Survival in Patients with Diabetes Mellitus, Hyperglycemia and Glioblastoma Multiforme. A Review of the Current Literature

Nicola Montemurro  1   2 , Paolo Perrini  1   2 , Biagio Rapone  3
Affiliations

Clinical Risk and Overall Survival in Patients with Diabetes Mellitus, Hyperglycemia and Glioblastoma Multiforme. A Review of the Current Literature

Nicola Montemurro et al. Int J Environ Res Public Health. .

Abstract

The relationship between type 2 diabetes mellitus (DM2) and hyperglycemia with cancer patients remains controversial also in the setting of patients with glioblastoma multiforme (GBM), the most common and aggressive form of astrocytoma with a short overall survival (OS) and poor prognosis. A systematic search of two databases was performed for studies published up to 19 August 2020, reporting the OS of patients with DM2 or high blood sugar level and GBM and the clinical risk of diabetic patients for development of GBM. According to PRISMA guidelines, we included a total of 20 papers reporting clinical data of patients with GBM and diabetes and/or hyperglycemia. The aim of this review was to investigate the effect of DM2, hyperglycemia and metformin on OS of patients with GBM. In addition, we evaluated the effect of these factors on the risk of development of GBM. This review supports accumulating evidence that hyperglycemia, rather than DM2, and elevated BMI are independent risk factors for poor outcome and shorter OS in patients with GBM. GBM patients with normal weight compared to obese, and diabetic patients on metformin compared to other therapies, seems to have a longer OS. Further studies are needed to understand better these associations.

Keywords: brain tumors; diabetes; glioblastoma; hyperglycemia; ketogenic diet; metformin; overall survival; risk factors; type 2 diabetes mellitus.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
PRISMA flow diagram.
See this image and copyright information in PMC

References

    1. Danaei G., Finucane M.M., Lu Y., Singh G.M., Cowan M.J., Paciorek C.J., Lin J.K., Farzadfar F., Khang Y., Stevens G.A., et al. National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: Systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2·7 million participants. Lancet. 2011;378:31–40. doi: 10.1016/S0140-6736(11)60679-X. - DOI - PubMed
    1. Seliger C., Ricci C., Meier C.R., Bodmer M., Jick S.S., Bogdahn U., Hau P., Leitzmann M.F. Diabetes, use of antidiabetic drugs, and the risk of glioma. Neuro Oncol. 2016;18:340–349. doi: 10.1093/neuonc/nov100. - DOI - PMC - PubMed
    1. Kaul K., Tarr J.M., Ahmad S.I., Kohner E.M., Chibber R. Introduction to diabetes mellitus. Adv. Exp. Med. Biol. 2012;771:1–11. doi: 10.1007/978-1-4614-5441-0_1. - DOI - PubMed
    1. Heidemann C., Boeing H., Pischon T., Nöthlings U., Joost H.G., Schulze M.B. Association of a diabetes risk score with risk of myocardial infarction, stroke, specific types of cancer, and mortality: A prospective study in the European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam cohort. Eur. J. Epidemiol. 2009;24:281–288. doi: 10.1007/s10654-009-9338-7. - DOI - PubMed
    1. Saltzman B.S., Doherty J.A., Hill D.A., Beresford S.A., Voigt L.F., Chen C., Weiss C.N. Diabetes and endometrial cancer: An evaluation of the modifying effects of other known risk factors. Am. J. Epidemiol. 2008;167:607–614. doi: 10.1093/aje/kwm333. - DOI - PubMed

Publication types